Cite
HARVARD Citation
McBride, S. et al. (2021). Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma. Journal of clinical oncology. 39 (1), pp. 30-37. [Online].